Federal contract award

75F40124P00523

THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) PURCHASE ORDER FOR DBPAP/ AMB A 1-SPECIFIC APTAMERS.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCB504 — Chemical/Biological Studies and Analysis
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$100.0K
Current contract value$100.0K
Potential contract value / ceiling$100.0K
Start dateSep 27, 2024
Current end dateSep 26, 2025
Potential end dateSep 26, 2025
Latest award activitySep 22, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 22, 2025P00001$0THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) PURCHASE ORDER FOR DBPAP/ AMB A 1-SPECIFIC APTAMERS.
Sep 27, 20240$100.0KTHE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) PURCHASE ORDER FOR DBPAP/ AMB A 1-SPECIFIC APTAMERS.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Nicholas BisherContactNicholas.Bisher@fda.hhs.govSourceSep 25, 2024
Nicholas BisherContactNicholas.Bisher@fda.hhs.govSourceSep 25, 2024
Nicholas BisherContactNicholas.Bisher@fda.hhs.govSourceSep 19, 2024

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.